Inclusion Body Myositis Market to Grow at Highest Pace Owing to Novel Therapeutics
Inclusion Body Myositis (IBM) is a rare, progressive muscle disorder characterized by muscle weakness and inflammatory vacuoles. The IBM market encompasses diagnostic assays, therapeutic biologics, and supportive care products designed to slow disease progression and improve patient quality of life. Advanced immunomodulators and monoclonal antibodies offer targeted action against inflammatory...
0 Commentarios 0 Acciones 104 Views 0 Vista previa